Safety of intravenous methylprednisolone therapy in patients suffering from systemic sclerosis

Scand J Rheumatol. 2010 Mar;39(2):178-9. doi: 10.3109/03009740903280085.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acute Kidney Injury / drug therapy*
  • Acute Kidney Injury / etiology
  • Adult
  • Blood Pressure / drug effects
  • Female
  • Humans
  • Male
  • Methylprednisolone / adverse effects*
  • Middle Aged
  • Retrospective Studies
  • Scleroderma, Systemic / complications
  • Scleroderma, Systemic / drug therapy*

Substances

  • Methylprednisolone